Skip to main content

Abcam PLC (ABCM)

NASDAQ: ABCM · Delayed Price · USD
20.79
-0.35 (-1.66%)
Pre-market:Sep 24, 2021 4:11 AM EDT
21.14
0.10 (0.48%)
At close: Sep 23, 4:00 PM
Market Cap4.74B
Revenue (ttm)410.62M
Net Income (ttm)22.34M
Shares Out226.78M
EPS (ttm)0.10
PE Ratio215.71
Forward PE66.67
Dividendn/a
Ex-Dividend Daten/a
Volume36,284
Open21.05
Previous Close21.04
Day's Range20.89 - 21.23
52-Week Range17.14 - 24.69
Beta0.58
AnalystsBuy
Price Target1,614.03 (+7,535.0%)
Est. Earnings Daten/a

About ABCM

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; cell line and lysates; an...

IndustryBiotechnology
IPO DateOct 22, 2020
CEOAlan Hirzel
Employees1,650
Stock ExchangeNASDAQ
Ticker SymbolABCM
Full Company Profile

Financial Performance

In 2021, Abcam PLC's revenue was 297.70 million, an increase of 14.50% compared to the previous year's 260.00 million. Earnings were 16.20 million, an increase of 29.60%.

Financial numbers in millions GBPFinancial Statements

Analyst Forecast

According to 2 analysts, the average rating for Abcam PLC stock is "Buy." The 12-month stock price forecast is 1,614.03, which is an increase of 7,534.96% from the latest price.

Price Target
$1,614.03
(7,534.96% upside)
Analyst Consensus: Buy

News

4 High Financial Strength Stocks Trading Near Historical Low Price-Book Ratios

According to the Historical Low Price-Book Screen, a Premium feature of GuruFocus, four stocks with high financial strength and are trading near historical low price-book ratios are Landstar System Inc....

Other symbols:JOBSLSTRSAP
1 week ago - GuruFocus

29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products ...

CAMBRIDGE, United Kingdom, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science research tools, to...

1 week ago - GlobeNewsWire

Abcam To Acquire Supplier BioVision For $340M In Cash

Abcam plc (NASDAQ: ABCM) has agreed to acquire BioVision Inc, a wholly-owned Boai NKY Medical Holdings Ltd subsidiary, for $340 million in cash. The Milpitas, California-based BioVision is a distributor...

1 month ago - Benzinga

Abcam to Acquire BioVision for $340 million

CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research tools,...

1 month ago - GlobeNewsWire

New Strong Sell Stocks for July 29th

ABCM, CCJ, EBMT, MRTN and NESR have been added to the Zacks Rank #5 (Strong Sell) List on July 29, 2021.

Other symbols:CCJEBMTMRTNNESR
1 month ago - Zacks Investment Research

Abcam opens new US facility in Boston, MA

CAMBRIDGE, July 13, 2021 /PRNewswire/ -- Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA.  The new...

2 months ago - PRNewsWire

Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients

SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, England, June 22, 2021 /PRNewswire/ -- Today Pionyr Immunotherapeutics, Inc., a company developing first-in-class antibody therapeutics that increase the body'...

3 months ago - PRNewsWire

2 of the Safest Biotech Stocks You'll Find Today

They provide the infrastructure and sell the tools that biomedical researchers need to make breakthroughs.

Other symbols:ARE
3 months ago - The Motley Fool

Abcam and MEDx extend precision medicine strategic partnership

CAMBRIDGE, United Kingdom and SHANGHAI, China, April 12, 2021 (GLOBE NEWSWIRE) -- Abcam (AIM: ABC; NASDAQ: ABCM), a global innovator in life science reagents and tools, and MEDx Translational Medicine (...

5 months ago - GlobeNewsWire

Avacta Announces Distribution Agreement With ABCAM plc

CAMBRIDGE, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to...

5 months ago - Business Wire

Abcam Wins Industry Awards from CiteAb

CAMBRIDGE, United Kingdom, March 24, 2021 (GLOBE NEWSWIRE) -- Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced that Dr Alejandra Solache, SVP of Resea...

5 months ago - GlobeNewsWire

8.3% constant currency revenue growth in H1 as customers gradually return to labs

CAMBRIDGE, United Kingdom, March 08, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; AIM: ABC) (“Abcam”, the “Group” or the “Company”), a global leader in the supply of life science research tools, to...

6 months ago - GlobeNewsWire

Abcam Expands Presence in China to Support Increased Demand of BioPharma Sector

CAMBRIDGE, United Kingdom, March 04, 2021 (GLOBE NEWSWIRE) -- Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced the expansion of its footprint in China...

6 months ago - GlobeNewsWire

Abcam to Report Interim Results on Monday, March 8, 2021

CAMBRIDGE, United Kingdom, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“Abcam” or the “Company”), a global leader in the supply of life science research tools, will report its ...

6 months ago - GlobeNewsWire

Abcam to present at the 2021 SVB Leerink Global Healthcare Conference

CAMBRIDGE, United Kingdom, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; LSE: ABC) today announced that Alan Hirzel, Chief Executive Officer, will present at the 2021 SVB Leerink Global Hea...

7 months ago - GlobeNewsWire

Abingdon Health signs collaboration and co-marketing agreement with Abcam

Abingdon Health signs collaboration and co-marketing agreement with Abcam

7 months ago - GlobeNewsWire

Abcam Plc Appointment of Non-Executive Directors

CAMBRIDGE, United Kingdom, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC; Nasdaq: ABCM) (“Abcam”), a global leader in the supply of life science research tools, is delighted to announce the appo...

7 months ago - GlobeNewsWire

Abcam: An Attractive, Profitable Medtech But Pricy

Abcam has a strong position in the niche of supplies for antibody research. It is profitable, dividend paying, and continues to grow well.

8 months ago - Seeking Alpha

Abcam plc: Annual Report, Impact Report and Notice of AGM

CAMBRIDGE, United Kingdom, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following release on 14 Se...

10 months ago - GlobeNewsWire

Abcam plc: Consultation on 2020 LTIP Awards

CAMBRIDGE, United Kingdom, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following consultation wit...

10 months ago - GlobeNewsWire